| | | Single nucleotide variant (intron variant) | Gilbert syndrome | |
| | | Single nucleotide variant (intron variant) | Gilbert syndrome | |
| | | Single nucleotide variant (intron variant) | Gilbert syndrome | |
| | | Single nucleotide variant (intron variant) | irinotecan response - Toxicity | |
| | | Insertion (intron variant) | UGT1A1-related disorder +1 more | |
| | | Single nucleotide variant (missense variant) | not specified +2 more | |
| | UGT1A5, UGT1A8 +8 more (P361L +4 more) | Single nucleotide variant (missense variant) | Hyperbilirubinemia +8 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant (intron variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | simvastatin acid response - Metabolism/PK +14 more | |
| | | Single nucleotide variant (intron variant) | Bilirubin, serum level of, quantitative trait locus 1 +1 more | |
| | | Single nucleotide variant (intron variant) | Gilbert syndrome +5 more | GConflicting classifications of pathogenicity |
| | UGT1A, UGT1A1 +8 more (Y486D +4 more) | Single nucleotide variant (missense variant) | Crigler-Najjar syndrome, type II +7 more | GPathogenic/Likely pathogenic |
| | UGT1A, UGT1A1 +8 more (G71R) | Single nucleotide variant (missense variant +1 more) | Crigler-Najjar syndrome, type II +4 more | GConflicting classifications of pathogenicity; drug response |
| | UGT1A, UGT1A1 +8 more (P229Q) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity; other |